Microbiologic aspects in patients with leukemia.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000941:Antigens / Q000032:analysis; D000970:Antineoplastic Agents / Q000009:adverse effects; D001419:Bacteria; D001424:Bacterial Infections / Q000209:etiology; D003386:Brachyura; D002177:Candidiasis / Q000209:etiology; D003428:Cross Infection / Q000517:prevention & control; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000172:deficiency; D017053:Infection Control; D007239:Infections / Q000175:diagnosis / Q000209:etiology*; D007938:Leukemia / Q000150:complications / Q000276:immunology / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000209:etiology; D009503:Neutropenia / Q000150:complications; D011528:Protozoan Infections / Q000209:etiology; D018805:Sepsis / Q000209:etiology; D013778:Tetrazolium Salts; D014691:Ventilation; D014777:Virus Diseases / Q000209:etiology
D000900:Anti-Bacterial Agents; D000941:Antigens; D000970:Antineoplastic Agents; D007136:Immunoglobulins; D013778:Tetrazolium Salts